DNAnexus is a leading cloud-based SaaS company serving the global life science community.
DNAnexus provides a cloud platform for governments, universities, doctors and pharmaceutical companies to tap into DNA and other clinical data sets and collaborate on scientific research projects.
DNAnexus was founded in 2009 by Stanford University professors Serafim Batzoglou and Arend Sidow and Stanford computer scientist Andreas Sundquist. The company is headquartered in Mountain View, California.
DNAnexus combines expertise in cloud computing and bioinformatics to create the global network for genomic medicine.
DNAnexus’ health informatics platform serves customers across a spectrum of industries — government, biopharmaceutical, clinical diagnostics, healthcare, and academic research in 33 countries with compliant protection of data, privacy, and intellectual property.
DNAnexus' platform provides a secure and collaborative environment where genomics, multi-omics, and real world data can be combined with clinical data at scale, providing new insights that can lead to improved diagnostics, new targeted therapies and better patient care.
DNAnexus' customers include eight of the top 10 clinical diagnostics companies, seven of the top 10 pharmaceutical companies, and prominent national medical centers. This global network supports some of the largest human genome sequencing projects in the world, as well as FDA’s precisionFDA platform.
DNAnexus is backed by GV, Perceptive Advisors, Northpond Ventures, Foresite Capital, TPG Capital, First Round Capital and others. The company raised $100M in new funding on June 09, 2020. This brings DNAnexus' total funding to $272.55M to date.